Fourth quarter 2007 Life Science Index sales rose 14.4% to $2,419 million, while operating profit jumped 29.8% to $445 million. Operating margins improved 220 basis points to 18.4% of revenues. Year-over-year Life Science Index sales increased 12.5% to $8,651 million. Operating profit grew 23.2% to $1,357 million, and operating margins increased 140 basis points to […]
Atomic Spectroscopy Applitek, a Belgian firm, debuted the eXaminer a portable/handheld X-ray fluorescence (XRF) instrument, which should begin shipping in August or September at a “competitive” price. In November 2007, Brooks Rand began shipment of the Merx methyl mercury system, which uses GC and its AFS mercury analyzer to make a direct measurement of methyl […]
Hopkinton, MA and San Diego, CA 2/26/08—Caliper Life Sciences has entered into a settlement agreement with AntiCancer, resolving the patent infringement suit that AntiCancer brought against Xenogen in 2005. Caliper acquired Xenogen in 2006 (see IBO 2/15/06). Under the settlement, Caliper acquired the right to sublicense AntiCancer’s fluorescent protein optical imaging patents, and AntiCancer acquired […]
PricewaterhouseCoopers reports that mergers and acquisitions (M&A) activity within the energy industry is expected to be weaker this year. In 2007, the total value of deals increased from $291.1 billion to $292.2 billion. Most of this increase took place in the downstream and oil services sectors. The total value of deals in the oil field […]
Cambridge Research & Instrumentation introduced the fully automated Maestro 2 in vivo optical imaging system in North America. Cambridge Research & Instrumentation released the Nuance 2, an affordable system that converts any brightfield or fluorescence microscope into a multispectral imaging workstation. Caliper Life Sciences launched drug combination services through Caliper Discovey Alliances & Services. Bio-Rad […]
Picarro signed exclusive distribution deals with Enviro Technology Services for the UK; ETG Risorse e Tecnologia for Italy; and Envitec for Belgium, the Netherlands, Luxemburg, France and Tunisia. Newport acquired Picarro’s Laser Products business in November 2007. The business has annual sales of $5–$7 million. Picarro named Michael Woelk president and CEO in November 2007. […]
In January, BioForce Nanosciences announced the sale of 11 Nano eNablers and the additional placement of 18 systems since the product’s introduction in 2006.
New Zealand’s Fast Forward plan is designed to transform the economy into a more formidable supplier of high value goods and services. Under the plan, the government will allocate NZ$700 million ($570 million) to the pastoral and food industries. The funding will grow interest over the next 10 to 15 years, and will be valued […]
Sepax Technologies is constructing a 100,000 sq. ft. Chromatography Science building in Changzhou, China to be completed in June 2008 for the production of columns, silica chemistry, polymer resin, bulk media and instruments, as well as for research of natural product separations and Chinese medicine. On January 1, Seika Corporation of America changed its name […]
Waters launched the SystemQT qualification tool, offering automated system-level quantification for Waters HPLC systems in order to reduce compliance test time. ESA Biosciences launched its Coulochem III ECD system with a Boron Doped Diamond electrode for the efficient analysis of sulfur-containing compounds. Varian launched its Pursuit family of Fast LC columns with the release of […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
